COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID

Objectives: Long COVID is a debilitating condition that impacts millions of Americans, but patients and clinicians have little information on how to prevent this disorder. Vaccination is a vital tool in preventing acute COVID-19 and may confer additional protection against Long COVID. There is limited evidence regarding the optimal timing of COVID-19 vaccination (i.e., vaccination schedule) to minimize the risk of Long COVID. Methods: We applied Longitudinal Targeted Maximum Likelihood Estimation to electronic health record (EHR) data from a retrospective cohort of patients vaccinated against COVID-19 between December 2021 and September 2022. We evaluated the association between binary COVID-19 vaccination status (two or more doses vs. zero doses) and 12-month Long COVID risk among patients diagnosed with acute COVID-19 between December 2021 and September 2022. In addition, we compared the 12-month cumulative risk of Long COVID (ICD-10 code U09.9) among patients diagnosed with acute COVID-19 one to three months after vaccination, three to five months after vaccination, or five to seven months after vaccination while adjusting for relevant high-dimensional baseline and time-dependent covariates. Results: = 1,085,291), we did not find a significant difference in Long COVID risk comparing patients who were diagnosed with acute COVID-19 one to three months after vaccination versus patients who were diagnosed with COVID-19 three to five months (adjusted marginal risk ratio 0.93 (95% CI 0.62, 1.41) or 5 to 7 months (adjusted marginal risk ratio 1.06 (95% CI 0.72, 1.56)) after vaccination. Conclusions: We found that COVID-19 vaccination before SARS-CoV-2 infection was protective against Long COVID, and we did not find that this protection significantly waned within 7 months after vaccination. These findings suggest that COVID-19 vaccination protects against Long COVID.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2026-07-24
DOI
https://doi.org/10.1016/j.ebiom.2026.106382
Citations
3
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
16.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID

Dan Housman, Greg Martin, Rena C. Patel, Amin Manna et al.
3 citations
EBioMedicine
Long-Term Effects of COVID-19
16.71
article

COVID-19 vaccination timing, relative to acute COVID-19, and subsequent risk of long COVID

Dan Housman, Greg Martin, Rena C. Patel, Amin Manna, Andrew N. Mertens, Alan Hubbard, Jing Sun, Yunwen Ji, Rachael V. Phillips, Jeremy Harper, Farrukh M. Koraishy, Emily Carlson Marti, Spratt Heidi, Sarang Deshpande, Hythem Sidky, Clare Schmitt, John M. Colford, Kenrick Cato, Kellie M Walters, D Eichmann, Jeremy Coyle, Alfred Anzalone, Lee Allan Pyles, McMurry Jf, Matvey B. Palchuk, Andrew T. Girvin, Benjamin Amor, Zachary Butzin-Dozier, Mary Saltz, Letianchu Wang, Mariam Deacy, Jaylyn Clark, Eric Hurwitz, Gagnier Jm, Joni L. Rutter, Elizabeth Zampino, Alexis Graves, Leonie Misquitta, Junming Shi, Amy Olex, Mark J. van der Laan, Caleb Alexander, Andrew Southerland, Adam B. Wilcox, Meredith Adams, Alfred (Jerrod) Anzalone, Mary Emmett, Carolyn Bramante, Christopher Chute, Andrea Zhou, John Buse, Lesley Cottrell, Hemalkumar Mehta, Emily R. Pfaff, Fred Prior, Eilis Boudreau, George Sokos, Johanna Loomba, D R Mazzotti, Justin Guinney, Benjamin Bates, Anita Walden, Kristin Kostka, Jami Pincavitch, Katie Rebecca Bradwell, Harold Lehmann, Chunlei Wu, Jessica Islam, Andrew E. Williams, Brijesh Patel, Marshall Clark, Elaine Hill, Mark M. Bissell, J.W. Awori Hayanga, Jomol Mathew, Lavance Northington, Ken Wilkins, Christine Suver, Federico Mariona, Kimberly Murray, Charisse Madlock-Brown, Evan French, Anjali A. Sharathkumar, Hongfang Liu, Jin Ge, Kenneth R. Gersing, Melissa A. Haendel, Justin Starren, Joel H. Saltz, Lili Portilla, Cavin Ward-Caviness, Cliff Takemoto, Christopher Dillon, Adam M. Lee, Brian Hendricks, Amit Saha, Davera Gabriel, Karen Crowley, Don Brown
article en
3 citations

Abstract

Objectives: Long COVID is a debilitating condition that impacts millions of Americans, but patients and clinicians have little information on how to prevent this disorder. Vaccination is a vital tool in preventing acute COVID-19 and may confer additional protection against Long COVID. There is limited evidence regarding the optimal timing of COVID-19 vaccination (i.e., vaccination schedule) to minimize the risk of Long COVID. Methods: We applied Longitudinal Targeted Maximum Likelihood Estimation to electronic health record (EHR) data from a retrospective cohort of patients vaccinated against COVID-19 between December 2021 and September 2022. We evaluated the association between binary COVID-19 vaccination status (two or more doses vs. zero doses) and 12-month Long COVID risk among patients diagnosed with acute COVID-19 between December 2021 and September 2022. In addition, we compared the 12-month cumulative risk of Long COVID (ICD-10 code U09.9) among patients diagnosed with acute COVID-19 one to three months after vaccination, three to five months after vaccination, or five to seven months after vaccination while adjusting for relevant high-dimensional baseline and time-dependent covariates. Results: = 1,085,291), we did not find a significant difference in Long COVID risk comparing patients who were diagnosed with acute COVID-19 one to three months after vaccination versus patients who were diagnosed with COVID-19 three to five months (adjusted marginal risk ratio 0.93 (95% CI 0.62, 1.41) or 5 to 7 months (adjusted marginal risk ratio 1.06 (95% CI 0.72, 1.56)) after vaccination. Conclusions: We found that COVID-19 vaccination before SARS-CoV-2 infection was protective against Long COVID, and we did not find that this protection significantly waned within 7 months after vaccination. These findings suggest that COVID-19 vaccination protects against Long COVID.

EBioMedicineVol. 130
University of North Carolina at Chapel Hill (US), Johns Hopkins University (US), University of Alabama at Birmingham (US), Berkeley Public Health Division (US), University of Nebraska Medical Center (US), University of California, Berkeley (US), Stanford University (US)
Bill and Melinda Gates Foundation, National Institute of Mental Health, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 2%
Long-Term Effects of COVID-19
16.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.